We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Achaogen Drug Gets Split Decision on Safety and Effectiveness for UTIs, Bloodstream Infections
Achaogen Drug Gets Split Decision on Safety and Effectiveness for UTIs, Bloodstream Infections
The FDA Antimicrobial Drugs Advisory Committee voted 15-0 that Achaogen’s NDA for plazomicin proved safety and effectiveness for complicated urinary tract infections in patients with limited or no treatment options.